Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Researchers test 250-year-old heart medicine in patients with deadly pancreatic cancer

Researchers repurpose a 250-year-old heart drug to target pancreatic cancer metabolism, aiming to improve survival rates below five percent, according to University of Skövde.

Summary by Medical Xpress
Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world's deadliest cancers.

2 Articles

News MedicalNews Medical
Center

Researchers test 250-year-old heart medicine in patients with deadly pancreatic cancer

Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world's deadliest cancers.

·United States
Read Full Article
Medical XpressMedical Xpress
Center

250-year-old drug enters clinical trial as potential treatment for deadly pancreatic cancer

Researchers in Sweden are testing a 250-year-old medicine in patients with one of the world's deadliest cancers.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Tuesday, October 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer icon

Cancer

Medical icon

Medical

Sweden icon

Sweden

News
For You
SearchBlindspotLocal